{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:50:53Z","timestamp":1781841053289,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05141-7","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:14:39Z","timestamp":1777752879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal 3\u2019tiRNA-PheGAA and interleukin-6 as novel biomarkers for non-invasive detection of NSCLC"],"prefix":"10.1007","volume":"17","author":[{"given":"Ning","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenJun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"3","key":"5141_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. 21834. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"5141_CR2","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.canep.2024.102693","volume":"93","author":"J Zhou","year":"2024","unstructured":"Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693. https:\/\/doi.org\/10.1016\/j.canep.2024.102693","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"5141_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020;383(7):640\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1916623","journal-title":"N Engl J Med"},{"issue":"6","key":"5141_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41571-019-0173-9","volume":"16","author":"DR Camidge","year":"2019","unstructured":"Camidge DR, Doebele RC, Kerr KM. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC. Nat Rev Clin Oncol. 2019;16(6):341\u201355. https:\/\/doi.org\/10.1038\/s41571-019-0173-9","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"5141_CR5","first-page":"383","volume":"83","author":"P Chantapet","year":"2000","unstructured":"Chantapet P, Riantawan P, Lebnak P, Getngern P. Utility of serum cytokeratin 19 fragment (CYFRA 21\u2009\u2013\u20091) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer. J Med Assoc Thai. 2000;83(4):383\u201391.","journal-title":"J Med Assoc Thai"},{"key":"5141_CR6","doi-asserted-by":"publisher","unstructured":"Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e142S-e65S. https:\/\/doi.org\/10.1378\/chest.12-2353","DOI":"10.1378\/chest.12-2353"},{"key":"5141_CR7","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.biopha.2023.115015","volume":"164","author":"M Nigam","year":"2023","unstructured":"Nigam M, Mishra AP, Deb VK, Dimri DB, Tiwari V, Bungau SG, et al. Evaluation of the association of chronic inflammation and cancer: Insights and implications. Biomed Pharmacother. 2023;164:115015. https:\/\/doi.org\/10.1016\/j.biopha.2023.115015","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"5141_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/0008-5472.CAN-15-2388","volume":"76","author":"GD Brooks","year":"2016","unstructured":"Brooks GD, McLeod L, Alhayyani S, Miller A, Russell PA, Ferlin W, et al. IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis. Cancer Res. 2016;76(4):866\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2388","journal-title":"Cancer Res"},{"issue":"8","key":"5141_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/08916934.2018.1550079","volume":"51","author":"H Tang","year":"2018","unstructured":"Tang H, Bai Y, Pan G, Wang X, Wei Y, Yang Z, et al. Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC. Autoimmunity. 2018;51(8):399\u2013407. https:\/\/doi.org\/10.1080\/08916934.2018.1550079","journal-title":"Autoimmunity"},{"key":"5141_CR10","doi-asserted-by":"publisher","unstructured":"Lee KWA, Chan LKW, Hung LC, Phoebe LKW, Park Y, Yi K-H. Clinical applications of exosomes: a critical review. Int J Mol Sci. 2024;25(14). https:\/\/doi.org\/10.3390\/ijms25147794.","DOI":"10.3390\/ijms25147794"},{"issue":"6","key":"5141_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654\u20139. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"issue":"6","key":"5141_CR12","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1080\/10408347.2024.2339961","volume":"55","author":"Q Liu","year":"2025","unstructured":"Liu Q, Zheng J, Xie A, Chen M, Gong RY, Sheng Y, et al. Exosome, a Rising Biomarkers in Liquid Biopsy: Advances of Label-Free and Label Strategy for Diagnosis of Cancer. Crit Rev Anal Chem. 2025;55(6):1136\u201347. https:\/\/doi.org\/10.1080\/10408347.2024.2339961","journal-title":"Crit Rev Anal Chem"},{"key":"5141_CR13","doi-asserted-by":"publisher","first-page":"117726","DOI":"10.1016\/j.bcp.2026.117726","volume":"246","author":"X Li","year":"2026","unstructured":"Li X, Pan Y, Zhou L, Qi L, Lu J. tRF-Gly-CCC-012 enhances malignant process in pancreatic cancer via the HNRNPC\/PHGDH axis. Biochem Pharmacol. 2026;246:117726. https:\/\/doi.org\/10.1016\/j.bcp.2026.117726","journal-title":"Biochem Pharmacol"},{"key":"5141_CR14","doi-asserted-by":"publisher","first-page":"8777697","DOI":"10.1155\/2022\/8777697","volume":"2022","author":"H Wang","year":"2022","unstructured":"Wang H, Huang W, Fan X, He X, Chen S, Yu S, et al. The tRNA-Derived Fragment tRF-24-V29K9UV3IU Functions as a miRNA-like RNA to Prevent Gastric Cancer Progression by Inhibiting GPR78 Expression. J Oncol. 2022;2022:8777697. https:\/\/doi.org\/10.1155\/2022\/8777697","journal-title":"J Oncol"},{"issue":"10","key":"5141_CR15","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1111\/cas.15505","volume":"113","author":"D Liu","year":"2022","unstructured":"Liu D, Wu C, Wang J, Zhang L, Sun Z, Chen S, et al. Transfer RNA-derived fragment 5\u2019tRF-Gly promotes the development of hepatocellular carcinoma by direct targeting of carcinoembryonic antigen-related cell adhesion molecule 1. Cancer Sci. 2022;113(10):3476\u201388. https:\/\/doi.org\/10.1111\/cas.15505","journal-title":"Cancer Sci"},{"key":"5141_CR16","doi-asserted-by":"publisher","first-page":"1037523","DOI":"10.3389\/fonc.2022.1037523","volume":"12","author":"B Zheng","year":"2022","unstructured":"Zheng B, Song X, Wang L, Zhang Y, Tang Y, Wang S, et al. Plasma exosomal tRNA-derived fragments as diagnostic biomarkers in non-small cell lung cancer. Front Oncol. 2022;12:1037523. https:\/\/doi.org\/10.3389\/fonc.2022.1037523","journal-title":"Front Oncol"},{"key":"5141_CR17","doi-asserted-by":"publisher","first-page":"110431","DOI":"10.1016\/j.abb.2025.110431","volume":"770","author":"L Wu","year":"2025","unstructured":"Wu L, Chen X, Chen D, Chen Q, Wu F. A novel tRNA-Derived fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1. Arch Biochem Biophys. 2025;770:110431. https:\/\/doi.org\/10.1016\/j.abb.2025.110431","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"5141_CR18","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s12094-024-03423-6","volume":"26","author":"J Peng","year":"2024","unstructured":"Peng J, Zhang Y, Zhou G, Shao L, Li L, Zhang Z. Circulating serum exosomes i-tRF-AspGTC and tRF-1-SerCGA as diagnostic indicators for non-small cell lung cancer. Clin Transl Oncol. 2024;26(8):1988\u201397. https:\/\/doi.org\/10.1007\/s12094-024-03423-6","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"5141_CR19","doi-asserted-by":"publisher","first-page":"e3737","DOI":"10.1002\/jgm.3737","volume":"26","author":"F Wu","year":"2024","unstructured":"Wu F, Chai B, Qi P, Han Y, Gu Z, Pan W, et al. Oncogenic tRNA-derived fragment tRF-Leu-CAG promotes tumorigenesis of lung cancer via targeting TCEA3 and increasing autophagy. J Gene Med. 2024;26(9):e3737. https:\/\/doi.org\/10.1002\/jgm.3737","journal-title":"J Gene Med"},{"issue":"1","key":"5141_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-022-01270-y","volume":"15","author":"W Yang","year":"2022","unstructured":"Yang W, Gao K, Qian Y, Huang Y, Xiang Q, Chen C, et al. A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1\/MED29 and ELK4\/MED29 axes. J Hematol Oncol. 2022;15(1):53. https:\/\/doi.org\/10.1186\/s13045-022-01270-y","journal-title":"J Hematol Oncol"},{"issue":"11","key":"5141_CR21","doi-asserted-by":"publisher","first-page":"113408","DOI":"10.1016\/j.celrep.2023.113408","volume":"42","author":"M Yu","year":"2023","unstructured":"Yu M, Yi J, Qiu Q, Yao D, Li J, Yang J, et al. Pan-cancer tRNA-derived fragment CAT1 coordinates RBPMS to stabilize NOTCH2 mRNA to promote tumorigenesis. Cell Rep. 2023;42(11):113408. https:\/\/doi.org\/10.1016\/j.celrep.2023.113408","journal-title":"Cell Rep"},{"issue":"6","key":"5141_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/carcin\/bgae010","volume":"45","author":"Y Shi","year":"2024","unstructured":"Shi Y, Pan Z, Feng Y, Zhou Q, Wang Q, Wang H, et al. tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5. Carcinogenesis. 2024;45(6):409\u201323. https:\/\/doi.org\/10.1093\/carcin\/bgae010","journal-title":"Carcinogenesis"},{"issue":"6","key":"5141_CR23","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1002\/jcp.27533","volume":"234","author":"Y Cui","year":"2019","unstructured":"Cui Y, Huang Y, Wu X, Zheng M, Xia Y, Fu Z, et al. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer. J Cell Physiol. 2019;234(6):8740\u201351. https:\/\/doi.org\/10.1002\/jcp.27533","journal-title":"J Cell Physiol"},{"issue":"7","key":"5141_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1593\/neo.13706","volume":"15","author":"Q Chang","year":"2013","unstructured":"Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, et al. The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia. 2013;15(7):848\u201362. https:\/\/doi.org\/10.1593\/neo.13706","journal-title":"Neoplasia"},{"issue":"1","key":"5141_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-024-02989-x","volume":"43","author":"Z Hu","year":"2024","unstructured":"Hu Z, Sui Q, Jin X, Shan G, Huang Y, Yi Y, et al. IL6-STAT3-C\/EBPbeta-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma. J Exp Clin Cancer Res. 2024;43(1):63. https:\/\/doi.org\/10.1186\/s13046-024-02989-x","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"5141_CR26","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/1759-7714.13991","volume":"12","author":"SQ Liu","year":"2021","unstructured":"Liu SQ, Ma XB, Song WM, Li YF, Li N, Wang LN, et al. Using a risk model for probability of cancer in pulmonary nodules. Thorac Cancer. 2021;12(12):1881\u20139. https:\/\/doi.org\/10.1111\/1759-7714.13991","journal-title":"Thorac Cancer"},{"issue":"7","key":"5141_CR27","doi-asserted-by":"publisher","first-page":"e0181125","DOI":"10.1371\/journal.pone.0181125","volume":"12","author":"EM Silva","year":"2017","unstructured":"Silva EM, Mariano VS, Pastrez PRA, Pinto MC, Castro AG, Syrjanen KJ, et al. High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer. PLoS ONE. 2017;12(7):e0181125. https:\/\/doi.org\/10.1371\/journal.pone.0181125","journal-title":"PLoS ONE"},{"issue":"11","key":"5141_CR28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798\u2013809. https:\/\/doi.org\/10.1038\/nrc2734","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"5141_CR29","doi-asserted-by":"publisher","first-page":"e12776","DOI":"10.1111\/cpr.12776","volume":"53","author":"W Liu","year":"2020","unstructured":"Liu W, Wang H, Bai F, Ding L, Huang Y, Lu C, et al. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-kappaB. Cell Prolif. 2020;53(3):e12776. https:\/\/doi.org\/10.1111\/cpr.12776","journal-title":"Cell Prolif"},{"key":"5141_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-7961-10-3","volume":"10","author":"DS Chi","year":"2012","unstructured":"Chi DS, Lin TC, Hall K, Ha T, Li C, Wu ZD, et al. Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1beta-activated human mast cells were inhibited by Baicalein via regulation of the NF-kappaB pathway. Clin Mol Allergy. 2012;10:3. https:\/\/doi.org\/10.1186\/1476-7961-10-3","journal-title":"Clin Mol Allergy"},{"key":"5141_CR31","doi-asserted-by":"publisher","unstructured":"Birrell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol. 2008;214(1):27\u201337. https:\/\/doi.org\/10.1002\/jcp.21158","DOI":"10.1002\/jcp.21158"},{"issue":"4","key":"5141_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/ATVBAHA.114.304960","volume":"35","author":"JW McEvoy","year":"2015","unstructured":"McEvoy JW, Nasir K, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(4):1002\u201310. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304960","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"5141_CR33","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/cam4.493","volume":"4","author":"ZH Zhang","year":"2015","unstructured":"Zhang ZH, Han YW, Liang H, Wang LM. Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer. Cancer Med. 2015;4(11):1633\u20138. https:\/\/doi.org\/10.1002\/cam4.493","journal-title":"Cancer Med"},{"issue":"2","key":"5141_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.lungcan.2011.11.012","volume":"76","author":"M Grunnet","year":"2012","unstructured":"Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138\u201343. https:\/\/doi.org\/10.1016\/j.lungcan.2011.11.012","journal-title":"Lung Cancer"},{"issue":"3","key":"5141_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4149\/neo_2022_220207N144","volume":"69","author":"M Li","year":"2022","unstructured":"Li M, Zhang Y, Jiang L, Li Y, Li G, Zhou J, et al. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker? Neoplasma. 2022;69(3):729\u201340. https:\/\/doi.org\/10.4149\/neo_2022_220207N144","journal-title":"Neoplasma"},{"issue":"4","key":"5141_CR36","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.21037\/tcr-21-527","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, Chen Y, Wang X, Wang C, Xiao M. The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer. Transl Cancer Res. 2021;10(4):1900\u20136. https:\/\/doi.org\/10.21037\/tcr-21-527","journal-title":"Transl Cancer Res"},{"issue":"1","key":"5141_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10238-025-01938-y","volume":"26","author":"X Li","year":"2025","unstructured":"Li X, Zhang W, Chen Y, Huang N, Jia X, Jing R, et al. Serum tRF-18-HR05X6D2 may serve as a promising potential diagnostic biomarker for gastric cancer. Clin Exp Med. 2025;26(1):15. https:\/\/doi.org\/10.1007\/s10238-025-01938-y","journal-title":"Clin Exp Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05141-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05141-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05141-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:58:25Z","timestamp":1781837905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05141-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5141"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05141-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research involving human subjects has been approved by the Ethics Committee of the Affiliated Taian Central Hospital of Qingdao University (Approval No.: 20230510). The research was conducted in accordance with local laws and regulations and institutional requirements. According to national laws and regulations and institutional requirements, participants and their legal guardians\/close relatives are not required to sign written informed consent forms. The principles of the Declaration of Helsinki have been followed. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}